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Objective To explore the experiences of women in Scotland who
return home to complete medical termination of pregnancy
(TOP) ≤63 days of gestation, after being administered with
mifepristone and misoprostol at an NHS TOP clinic.
Design Qualitative interview study.
Setting One National Health Service health board (administrative)
area in Scotland.
Population or Sample Women in Scotland who had undergone
medical TOP ≤63 days, and self-managed passing the pregnancy
at home; recruited from three clinics in one NHS health board
area between January and July 2014.
Methods In-depth, semi-structured interviews with 44 women in
Scotland who had recently undergone TOP ≤63 days of gestation,
and who returned home to pass the pregnancy. Data were
analysed thematically using an approach informed by the
Framework method.
Main outcome measures Women’s experiences of self-
management of TOP ≤63 days of gestation.
Results Key themes emerging from the analysis related to self-
administration of misoprostol in clinic; reasons for choosing
home self-management; facilitation of self-management and
expectation-setting; experiences of getting home; self-managing
and monitoring treatment progress; support for self-management
(in person and remotely); and pregnancy self-testing to confirm
completion.
Conclusions Participants primarily found self-administration of
misoprostol and home self-management to be acceptable and/or
preferable, particularly where this was experienced as a decision
made jointly with health professionals. The way in which home
self-management is presented to women at clinic requires ongoing
attention. Women could benefit from the option of home
administration of misoprostol.
Keywords First trimester medical/medication abortion, home self-
management, qualitative research, termination of pregnancy,
women’s experiences.
Tweetable abstract Women undergoing medical TOP 63 days
found home self-management to be acceptable and/or preferable.
Please cite this paper as: Purcell C, Cameron S, Lawton J, Glasier A, Harden J. Self-management of first trimester medical termination of pregnancy:
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Introduction
Recent World Health Organization guidance includes the
option of home self-management for first trimester medical
termination of pregnancy (TOP).1 However, the current
interpretation of British legislation*– the 1967 Abortion
Act which governs provision in Scotland, Wales and
England – is that both TOP medications (mifepristone and
misoprostol) must be administered on National Health Ser-
vice (NHS) premises. With the development of safe, reli-
able treatment regimens for TOP ≤63 days of gestation has
come the option for women in Britain to return home to
self-manage passing the pregnancy, after misoprostol has
been administered at an outpatient clinic.
Research suggests that women self-managing first trime-
ster TOP have varied experiences2–4 but are no more likely
to re-attend with complications than those treated in
*We deliberately use ‘Britain’/’British’ here, rather than ‘UK’, as the latter
includes Northern Ireland, where access is much more severely restricted.
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hospital.5 Although a growing body of literature suggests
that self-management is acceptable to women,2,6–17 there is
a need to monitor and understand women’s needs around
this model of provision, to facilitate provision of the best
possible support. Our research contributes to this under-
standing, by examining details of women’s experiences of
self-management ≤63 days, of which to date, relatively little
is known.
In Britain, home self-management is becoming increas-
ingly established practice, and is now the default option
for eligible women in many NHS and independent clin-
ics.** 14,15 Women are also commonly given the option
vaginally to self-administer misoprostol at the clinic. This
paper draws on data from one Scottish NHS health
board area, where women are typically treated over two
clinic visits,18,19 and in which around 77% of TOP
≤63 days (55% of all terminations) are completed at
home.5 The first visit involves counselling and adminis-
tering mifepristone; and the second, provision of miso-
prostol and post-TOP contraception.18 At the time of
fieldwork, clinic protocol specified that women should be
given a choice between home self-management and hos-
pital care.***
The objective of the wider study was to evaluate provi-
sion of TOP ≤63 days from the perspectives of women and
health professionals.18,19 This paper focuses on the former,
with the aim of understanding and exploring women’s
experiences, in order to inform service developments and
future provision, where TOP has until recently been pro-
vided exclusively in a hospital setting.
Method
A qualitative research design offered flexibility to women
in discussing their experiences of TOP in their own
words.20 Recruiting sites – one community sexual and
reproductive health (SRH) clinic, two hospital-based clin-
ics in one NHS area – served an urban/peri-urban popu-
lation, with women typically travelling for <1 hour to
attend, and had been offering home self-management for
approximately 18 months prior to this study. Specialist
health professionals provided study details to women
attending for medical TOP ≤63 days, under Ground C of
the 1967 Abortion Act (i.e. for psychosocial rather than
medical indications). Over a 6-month recruitment period
(January–July 2014), 135 women completed an ‘opt-in’
contact form, agreeing to be contacted by C.P. at a later
date. C.P. made contact approximately 2 weeks later to
arrange an interview. Six women were ineligible, two
explicitly withdrew, and 81 were un-contactable within
the specified 6-week timeframe. We did not conduct pur-
posive sampling beyond the aim of recruiting an equal
number of women who had presented in each of two
clinical contexts (hospital and community SRH), compar-
ison of which was of interest to the broader study. Inter-
views were conducted 3–5 weeks following TOP, in a
location of the woman’s choosing or by telephone.
Recruitment and interviewing continued until data satura-
tion was achieved; that is, when no new findings emerged
from new data collected. Written consent was obtained
prior to the interviews.
A flexible topic guide was developed in light of literature
reviews and input from the study Advisory Group. Inter-
views explored TOP experiences, including interaction with
health professionals, home self-management and contracep-
tion.17 Interviews were digitally recorded and transcribed in
full. Participants received a £15 voucher as compensation
for their time.
A thematic analytical approach informed by the Frame-
work method21 was undertaken by C.P. and J.H., who
repeatedly read interview transcripts, before meeting to dis-
cuss and compare interpretations, and identify key themes.
A coding framework was developed and applied to tran-
scripts based on initial themes identified. Coded data sets
were further analysed to identify linkages between themes
and explore similarities and differences across accounts.
NVIVO 10 qualitative data analysis software (QSR Interna-
tional 2012, Melbourne, Vic., Australia) facilitated coding
and data management. Where data extracts are presented,
identifiers in brackets indicate participant identifier and
age.
Results
We conducted in-depth interviews with 44 women who
had recently undergone medical TOP ≤63 days,*** and
who had self-managed passing the pregnancy at home. Key
characteristics of participants are outlined in Table 1.
Issues relating to self-management were clustered around
two broad themes: women’s introduction to self-manage-
ment at the clinic, and experiences of self-management at
home. Our analysis addresses different components of
each, including: misoprostol self-administration at clinic;
choosing home self-management; expectation-setting by
health professionals; getting home; self-management and
**In some circumstances a woman may remain in hospital as a ‘day case’:
for example, if she has a higher likelihood of medical complications, if she
lives more than an hour from a hospital, if there are concerns about her
safety or she has no-one to be with her, if she speaks limited English.
***Our sample thus represents approximately 5% of all women (n = 867)
who had medical abortion ≤63 days in the recruiting area within the 6-
month recruitment period (figure provided by Information Service Divi-
sion, personal communication 8 February 2017). Two interviewees were
excluded from the analysis presented here as they had received hospital
treatment.
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monitoring treatment progress; support for self-manage-
ment; and home pregnancy testing to confirm completion.
Introducing self-management at the clinic
Misoprostol self-administration: ‘I was happy to do it
myself’
For most participants, a degree of self-management began
with vaginal self-administration of misoprostol at clinic.
There was variation in the degree to which women felt this
was optional and/or standard practice. Most saw it as rela-
tively unproblematic and were relieved to self-administer.
However, some described feeling nervous about inserting
the tablets correctly and preferred the nurse to do this:
I says ‘well, to be honest, I would rather you did, because
at least I know it’s done properly’. So she went, ‘that’s
no problem’. (SR21, 43)
Self-administration, combined with a relatively brief
appointment, led some to question why misoprostol could
not be provided to take home at the mifepristone appoint-
ment, rather than having to re-attend 1–2 days later:
Why does it have to take that long if I’m putting the pills
in myself? [. . .] Why can they not give you that on that
day and say ‘tomorrow, stick these four pills up you?
‘Just to go in and do that for five minutes seems point-
less to me. (H111, 26)
Why home self-management? ‘I’d rather be in the privacy of
my own home’
Some participants reported initial surprise that home self-
management was an option. The vast majority of women
said that the privacy and comfort of their own surround-
ings was their preferred option:
What they’d said was – and I was in agreement –
‘You’d probably be way more comfortable at home.
[. . .] You can do it in a hospital environment. . .’ But
100% I’d much rather be at home with a telly and
some ice-cream. It’s good to have the option, but defi-
nitely at home [you’re] much more comfortable in your
own bed. (SR22, 21)
Some participants were concerned with making undue
use of NHS resources.
I didn’t want to go to the hospital because I didn’t want
to take up a bed for six hours. I was really conscious of
wasting the NHS’s time, because I felt. . . like that was
not necessary, and it was my own fault. (SR20, 21)
Some women also preferred to go home because they felt
uncomfortable about the hospital TOP service’s location
adjacent to maternity services, and were worried about
being judged by service users.
There was, again, variation in the extent to which
women perceived home self-management as optional. Some
understood this to be the default treatment mode, with day
wards reserved for exceptional cases. This included a
minority who felt that they had not been given, or been
able to request, day ward treatment.
I really wanted to stay in, but I never got the option for it. I
think they maybe should let people stay in to definitely
make sure it’s all away [. . .] I never mentioned it because I
knew they weren’t going to let me stay in. They were like
‘it’s very rare for people to stay in’. So they were just like
‘see you later, go home’ basically. (H115, 22)
However, the presentation of home self-management as
the default care pathway left most feeling relatively safe and
unconcerned:
I don’t remember feeling like I had a choice. It pretty
much just sounded like: ‘this is the normal procedure,
this is what we do’. So I wasn’t concerned. (H107, 30)
Expectation-setting: ‘I felt fully informed’
For all women who self-managed at home, information
and advice from health professionals were crucial in assur-
ing their comfort with this option. Participants described
how health professionals had provided substantial amounts
of information, with the appointment feeling like ‘lots of
bits of paper, lots of pills’ (SR20, 21). As well as providing
Table 1. Sample characteristics
Age (years) Total
(n = 44)
(% of
total)
Mean 26.8
Median 23
Range 18–43
Highest education attained
Secondary school 14 31.9%
Further education (e.g. college) 13 29.5%
Higher education (i.e. university) 13 29.5%
Postgraduate 4 9.1%
Relationship status (at interview)
Single 8 18.1%
Cohabiting/married 18 40.9%
In relationship (not cohabiting) 17 38.7%
Separated 1 2.3%
Employment status
In paid employment 31 70.5%
Student 7 15.9%
Not in paid employment/full-time
parent
6 13.6%
Children 15 34.1%
Previous termination of pregnancy 7 15.9%
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analgesics, much of the information related to expectation-
setting and advising women of circumstances in which they
should seek help, which left most participants feeling
appropriately informed:
They explain everything to you. I got a brown bag full of
information. She spoke to me for about 20 minutes:
emergency numbers, absolutely everything. (H104, 23)
As a result of health professionals’ frank descriptions,
participants also reported having a clear sense of what was
‘normal’:
She was very matter-of-fact about it, she said: ‘Within
15 minutes once you’d inserted the tablets you’ll start
getting symptoms and the pain will build up. You’ll
probably start bleeding quite a lot. Then, over the next
four hours, you should pass a very large clot, or several
large clots. Once that’s happened the pain should start
dissipating [. . .] They give you a scenario where you’re
bleeding out more than you should be and therefore you
should be phoning up. (SR23, 38)
Where experiences at home were congruent with what
women had been given to expect, they reported these expe-
riences as broadly acceptable. After they had received these
descriptions, factors about which participants said that they
had continued to feel anxious or unsure included what
expulsion would feel like, and what the pregnancy tissue
would look like (see below).
Home self-management
Women’s accounts of self-management focused around
pain, bleeding and passing the pregnancy, echoing experi-
ences from clinic settings.22 Here we focus on how these
experiences were shaped by their passing the pregnancy at
home.
Getting home: ‘I started feeling quite ill in the car’
Participants described a range of experiences when travel-
ling home from the clinic following misoprostol adminis-
tration. Several felt nauseous or started cramping, while
others recalled severe pain beginning:
Oh it started in the car [. . .] I was in agony, I was saying
to my partner ‘oh my god, it’s kicking in, I’m getting
really bad pains!’ So I got home and I just got into my
pyjamas and went straight into bed (H206, 25)
While some women were relatively untroubled by the
onset of symptoms during the journey – viewing it as a
necessary evil, endured in order to get home – others felt
frightened, upset or exposed. For women who knew no-
one with a car and/or could not afford a taxi, coping with
the onset of pain and bleeding on public transport was par-
ticularly challenging and frustrating:
When I was on the bus I could feel that I was bleeding a
lot [. . .] I was really tired. I was just kind of, y’know:
‘I’ve spent 45 minutes on a bus for a two-minute
appointment..?’ (SR06, 27)
Being at home: ‘Being at home is really the best thing’
The vast majority of women said they valued the option to
return home, as it had afforded them dignity and privacy
that they expected would be absent in hospital:
It’s such a physical and emotional process so, y’know, at
home’s better. Hugely. You basically need to like make
friends with your toilet for eight hours, so it kind of
works at home better. (SR02, 37)
[It was] definitely the right decision. I think that would
be so much more traumatic if you did that in a hospital.
(C.P.: In what sort of way, d’you think?) I just think it
would be so. . . not ‘humiliating’, that’s not the right
word, but just so public. I was such a mess. I would be
so embarrassed for people to see me like that. . . ‘
(SR01, 21)
While not an absolute, those who reported that they
might have preferred hospital-based care were also those
whose experiences were less congruent with the expecta-
tions set by clinic staff, and who did not necessarily feel
that they had been given a choice.
Monitoring treatment progress: ‘Like two almighty periods
in eight hours’
Many women noted the importance of the information
provided by nurses which prepared them for the process,
and enabled them to assess its progression:
It’s good to do it at home, but I think a good level of
honesty from the nurse [is helpful], because it’s on the
cusp of being cope-able with. (SR23, 38)
In the absence of a nurse’s assessment, bleeding was per-
ceived as an indicator of efficacy. Having been briefed that
bleeding was likely to be very heavy, some women had con-
cerns about whether treatment had worked when bleeding
was relatively light. A minority described surprise at the
volume of bleeding, and some difficulty managing this:
That day was absolutely horrific. I bled so much. I didn’t
think it’d be as much as that and as much clotting and
stuff. I was literally sitting on the toilet for half an hour
at a time, because every time you stood up it just was
pouring out [. . .] You couldn’t get to the bathroom fast
enough, it was just coming in force. [. . .] I had to go in
the shower cause I’d leaked, and then you’re standing in
the shower and it’s just pouring out and obviously you’re
seeing all the clots and I’m like ‘oh my god!’ (H202, 22)
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Several participants reported that – as clinic staff advised
they would – they had recognised when they had passed the
bulk of the pregnancy tissue, and this had brought relief.
Others were unsure whether this had occurred, and whether
the TOP had been successful. Some women reported unease
at the unfamiliar sensation of passing larger clots:
Y’know, sometimes if you’ve got your period, and you’re
sitting still for ages, and you stand up and you can kind
of feel it? It was sort of like that. But I was on the toilet
and it almost felt a little bit like. . . jelly, a little bit
clotted. (SR10, 26)
Many women reported being advised by health profes-
sionals not to look at what they had passed, or that there
would be nothing to see at such an early gestation. A small
minority reported seeing what they believed to be a recog-
nisable fetus, were distressed by this, and regretted looking:
[I] just felt compelled, that I had to look. So that’s when
I knew [TOP had been effective]. [. . .] In hindsight I
wish I hadn’t looked but I did, and that was probably the
most traumatic thing I’ve ever seen or done. I thought
‘what on earth..?’ (H201, 35)
Support in person: ‘going through it together’
Participants reported that they had all been strongly advised
to have an adult with them for 24 hours after taking miso-
prostol, and the majority were supported at home to varying
degrees by their partner (and a smaller number by a female
friend/family member). Some reported that male partners
had found the process challenging – feeling ‘useless’ or ‘help-
less’ (H107, 30) – and some voiced a preference for hospital
care, even where this was not the woman’s preference. Those
in relatively new relationships felt embarrassment that their
partner had seen them go through the more visceral aspects
of medical TOP, but nevertheless felt grateful that they had
been able to go through it together at home.
Although most women had someone stay with them,
some had preferred to be alone, and felt that having
another person present would create additional distress:
[Friend] wanted to stay but I told her to go home, and I
was so glad I did, because if she’d been in here and seen
me screaming like that, she’d have phoned an ambulance.
She would’ve panicked. (H201, 35)
Women in this position nonetheless had someone nearby
and available by phone.
Support at a distance: ‘Knowing that I could pick up the
phone at any time helped’
Many participants reported being informed at clinic that
telephone support would be available from clinic staff if
needed, though not all had required it:
[The] senior nurse gave me her mobile number and told
me I could ring her if I wanted, if I had any questions,
or if I was worried about anything, or if anything unex-
pected happened [. . .] So I thought that was a really nice,
like, ‘OK, I’m not alone here’. (SR01, 21)
For those who sought support, the reassurance provided
by nurses was generally felt to be invaluable, particularly
where experiences differed from what had been expected.
I phoned them [. . .] and I says to them ‘listen, is this
[ongoing cramping] normal? I know that you gave me
painkillers but I expected to maybe take them on the
[day] but not so many days later.’ And they were like
‘it’s totally normal [. . .] it’s absolutely fine’. So again,
[this] put my mind at ease. (SR21, 43)
Whether or not women had sought phone support, they
reported feeling reassured that this was an option, and that
they would not be required to explain their situation, as
those answering the call would be aware that they were
undergoing TOP.
Home pregnancy testing: ‘Thankfully it came back negative,
so it’s all done and dusted’
All participants had been provided with a low-sensitivity
urine pregnancy (LSUP) test to be performed 2 weeks after
TOP. Some reported initial anxieties around self-adminis-
tering the test:
At first I did think ‘what if I do it wrong?’ and ‘what if I
still am?’ and ‘would I prefer the professionals to do it?’
But you couldn’t really do it wrong. And the symptoms
sort of went away anyway, so I knew. So that was fine.
(SRH21, 43)
Several women had not taken the test as they felt the
physical signs of pregnancy had dissipated, and thus judged
that the treatment had been successful. Most said they were
happy with the self-test, because it both confirmed that
they were no longer pregnant and meant they would not
require further contact with TOP services.
Discussion
Main findings
There is an urgent need to better understand what the
shift toward self-management in TOP care means for
women. Our analysis demonstrates that women see home
self-management as beneficial, offering a potentially more
comfortable space in which to go undergo TOP, and the
opportunity to have support from a partner, friend or
family member. Our findings highlight potential areas for
improvement, primarily around the degree to which miso-
prostol self-administration and home self-management are
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conveyed to women as optional. Our analysis suggests
that, although home was the preferred option for most,
it is essential that the alternative of hospital care is made
clear. This potentially requires a delicate balancing act
for health professionals between normalising home self-
management and facilitating joint decision-making and
choice.
Strengths and limitations
A limitation to the study is that all women were recruited
from one NHS health board area, where a significant pro-
portion of women self-manage TOP ≤63 days and, at the
time of fieldwork, home self-management had been an
option for over a year. It also drew on a relatively small
sample, which did not allow for comparison with hospital-
managed care. Given the body of literature that suggests a
tendency for recipients of healthcare to evaluate any care
they receive positively,23 doing so may have produced a
quite different picture. However, the richness of the data
generated has enabled identification of a range of experi-
ences, and new areas as yet unexplored in the literature on
first trimester medical TOP.
Interpretation (in light of other evidence)
Our findings add weight to existing evidence which has
suggested that women undergoing TOP ≤63 days are lar-
gely amenable to self-management and that, although they
may experience some initial anxieties, they tend to express
overall satisfaction.2,24–26 Crucially, our analysis suggests
that women value being given choices and feeling involved
in decisions about their treatment,4,14,17,27,28 and goes some
way to address concerns raised by providers about how
women might cope at home.18 Our analysis also highlights
that women’s perceptions of their overall experiences were
more negative when self-management was not their pre-
ferred option, or when they did not feel involved in treat-
ment decision-making. This brings out the significance of
offering women options in the TOP pathway, including
whether and how to self-administer misoprostol (i.e.
vaginally or sublingually/buccally), and where to pass the
pregnancy.
Our findings are supported by existing literature which
has highlighted the vital role health professionals play in
information provision and expectation-setting.27–29 The
results also underscore the importance to women embark-
ing on TOP of feeling that they know what to expect, are
in control, and that they have and are having an experience
congruent with what they perceive health professionals
have led them to expect. Our findings resonate with
research which suggests that much of women’s anxieties
around TOP are grounded not in the decision to end the
pregnancy but in apprehension concerning an unknown
process.27–30 Clearly informing women of what to expect of
TOP is crucial to ensuring their safety and comfort, and to
facilitating that sense of control.2,27,28 However, health pro-
fessionals also need to convey the potential for variation in
experiences of medical TOP, and are therefore required to
strike a delicate balance between the specific detail that
(some) women want and the range of experiences that they
may face. Effectively striking this balance simultaneously
affords women greater agency in the process, and maintains
the place of first trimester TOP self-management within
the bounds of medical care.19
One current gap in this regard appears to be around
experiences of passing larger clots/pieces of pregnancy tis-
sue. It may be that this remains a relatively taboo aspect of
the process, which health professionals find more challeng-
ing to verbalise; or it may be that this has not previously
been flagged to providers as information which women
undertaking self-management want. Either way, this
emerged as a significant, and for many women surprising,
component of first trimester medical TOP.
Our analysis suggests that the comfort and privacy
afforded by self-management enabled women to cope with
treatment in a way that suited them, without concerns
about how they were being perceived by strangers, as they
might in a hospital setting. This echoes the suggestion that
self-management can facilitate alternative experiences of
TOP.2 Significantly, our findings shed further light on the
essential role of available support (in this case by tele-
phone) from health professionals during and following
TOP.2 Given the potential variability of women’s experi-
ences of pain and bleeding, it is vital that those undergoing
self-management have the option to seek advice and reas-
surance as needed. The invaluable role that this support
played for women in our study also underlines the implica-
tions for those to whom such a service is not available, and
where TOP is not legally provided.4
Safe medical regimens offer advantages to women under-
going first trimester TOP, and the potential to develop self-
management further. In the British context, however, the
current interpretation of the 1967 Abortion Act requires
TOP medications to be administered on NHS premises.
Hence, the opportunity to extend self-management – to
include, for example, home administration of misoprostol
– is currently constrained, despite the significant issues an
additional clinic visit can create for women.31 Given the
significant changes in provision in the 50 years since it was
passed, we echo the suggestion14 that the 1967 Abortion
Act and its interpretation should be revisited, in order to
facilitate further improvement in patient-centred TOP care.
Conclusion
This study explored the experiences of women who had
self-managed medical TOP ≤63 days of gestation, in a
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context where provision has until recently been hospital-
based. Our findings highlight that women valued self-
management, from self-administration of misoprostol at
clinic, through passing the pregnancy, to confirming TOP
completion via a self-performed LSUP test. It also brings to
the fore the need to maintain high standards of informa-
tion provision and appropriate support for women under-
going TOP in this model.
Disclosure of interests
None declared. Completed disclosure of interests form
available to view online as supporting information.
Contribution to authorship
The paper was devised by C.P., and the first draft written
by C.P. in consultation with J.H. S.C., J.L. and A.G. pro-
vided comments on this draft, and all authors approved
the final version.
Details of ethics approval
The study was reviewed and granted ethical approval by
the Centre for Population Health Sciences Ethics Commit-
tee, University of Edinburgh (3 March 2014).
Funding
The study was funded by the Chief Scientist Office for
Scotland, grant number CZH/4/906. The research was con-
ducted while C.P. was a Research Fellow at the University
of Edinburgh, and the paper drafted while she was a
Research Associate at the MRC/CSO Social and Public
Health Sciences Unit, University of Glasgow (MC_UU_
12017/11, SPHSU11).
Acknowledgements
The authors would like to thank the women who were will-
ing to participate in the study, and the clinic staff who
assisted with recruitment.&
References
1 World Health Organization. Health worker roles in providing safe
abortion care and post abortion contraception. [http://apps.who.int/
iris/bitstream/10665/181041/1/9789241549264_eng.pdf 2015] Accessed
13 February 2017.
2 Wainwright M, Colvin CJ, Swartz A, Leon N. Self-management of
medical abortion: a qualitative evidence synthesis. Reprod Health
Matters 2016;24:155–67.
3 Astle H, Cameron ST, Johnstone A. Comparison of unscheduled re-
attendance and contraception at discharge, among women having
the final stage of early medical abortion at home and those
remaining in hospital. J Fam Plann Reprod Health Care 2012;38:
35–40.
4 Kallner HK, Fiala C, Gemzell-Danielsson K. Assessment of significant
factors affecting acceptability of home administration of misoprostol
for medical abortion. Contraception 2012;85:394–7.
5 Cameron ST, Glasier A, Johnstone A. Comparison of uptake of
long-acting reversible contraception after abortion from a hospital
or a community sexual and reproductive healthcare setting: an
observational study. J Fam Plann Reprod Health Care 2017;43:31–6.
6 Hedqvist M, Brolin L, Tyden T, Larsson M. Women’s experiences of
having an early medical abortion at home. Sex Reprod Healthc
2016;9:48–54.
7 Aitken AA, Gomperts R, Trussell J. Experiences and characteristics
of women seeking and completing at-home medical termination
of pregnancy through online telemedicine in Ireland and
Northern Ireland: a population-based analysis. BJOG 2016;124:
1208–15.
8 Cameron S, Glasier A, Dewart H, Johnstone A. Women’s experiences
of the final stage of early medical abortion at home: results of a pilot
survey. J Fam Plann Reprod Health Care 2010;36:213–6.
9 Chong E, Frye LJ, Castle J, Dean G, Kuehl L, Winikoff B. A
prospective, non-randomized study of home use of mifepristone for
medical abortion in the US. Contraception 2015;92:215–9.
10 Gold M, Chong E. If we can do it for misoprostol, why not for
mifepristone? The case for taking mifepristone out of the office in
medical abortion. Contraception 2015;92:194–6.
11 Hamoda H, Ashok PW, Flett GM, Templeton A. Home self-
administration of misoprostol for medical abortion up to 56 days’
gestation. J Fam Plann Reprod Health Care 2005;31:189–92.
12 Kallner HK, Fiala C, Stephansson O, Gemzell-Danielsson K. Home
self-administration of vaginal misoprostol for medical abortion at
50–63 days compared with gestation of below 50 days. Human
Reprod 2010;25:1153–7.
13 Li CL, Song LP, Tang SY, Zhou LJ, He H, Mo XT, et al. Efficacy,
Safety, and acceptability of low-dose mifepristone and self-
administered misoprostol for ultra-early medical abortion a
randomized controlled trial. Reprod Sci 2016;24:731–37.
14 Lohr PA, Wade J, Riley L, Fitzgibbon A, Furedi A. Women’s opinions
on the home management of early medical abortion in the UK. J
Fam Plann Reprod Health Care 2010;36:21–5.
15 Cameron ST, Glasier A, Johnstone A. Shifting abortion care from a
hospital to a community sexual and reproductive health care setting.
J Fam Plann Reprod Health Care 2016;42:127–32.
16 Ngoc NTN, Nhan VQ, Blum J, Mai TTP, Durocher JM, Winikoff B. Is
home-based administration of prostaglandin safe and feasible for
medical abortion? Results from a multisite study in Vietnam. BJOG
2004;111:814–9.
17 Swica Y, Chong E, Middleton T, Prine L, Gold M, Schreiber CA,
et al. Acceptability of home use of mifepristone for medical
abortion. Contraception 2013;88:122–7.
18 Purcell C, Cameron S, Lawton J, Glasier A, Harden J. Contraceptive
care at the time of medical abortion: experiences of women and
health professionals in a hospital or community sexual and
reproductive health context. Contraception 2016;93:170–7.
19 Purcell C, Cameron S, Lawton J, Glasier A, Harden J. The changing
body work of abortion: a qualitative study of the experiences of
health professionals. Sociol Health Illness 2017;39:78–94.
20 Pope C, Mays N. Qualitative research: reaching the parts other
methods cannot reach: an introduction to qualitative methods in
health and health services research. BMJ 1995;311:42.
21 Spencer L, Ritchie J, Ormiston R, O’Connor W, Barnard M. Analysis.
In: Ritchie J, Lewis J, Nicholls CM, Ormiston R editors. Qualitative
Research Practice. London: Sage, 2014.
22 Lie ML, Robson SC, May CR. Experiences of abortion: a narrative
review of qualitative studies. BMC Health Serv Res 2008;8:150.
23 McKay RJ, Rutherford L. Women’s satisfaction with early home
medical abortion with telephone follow-up: A questionnaire-based
study in the UK. J Obstet Gynaecol 2013;33:601–4.
2007ª 2017 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley& Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Experiences of TOP self-management in Scotland
24 Raymond EG, Grossman D, Wiebe E, Winikoff B. Reaching women
where they are: eliminating the initial in-person medical abortion
visit. Contraception 2015;92:190–3.
25 Gomperts RJ, Jelinska K, Davies S, Gemzell-Danielsson K, Kleiverda
G. Using telemedicine for termination of pregnancy with
mifepristone and misoprostol in settings where there is no access to
safe services. BJOG 2008;115:1171–8.
26 Avis M, Bond M, Arthur A. Questioning patient satisfaction: an empirical
investigation in two outpatient clinics. Soc Sci Med 1997;44:85–92.
27 Fielding SL, Edmunds E, Schaff EA. Having an abortion
using mifepristone and home misoprostol: a qualitative analysis of
women’s experiences. Perspect Sex Reprod Health 2002;34: 34–40.
28 Kero A, Wulff M, Lalos A. Home abortion implies radical
changes for women. Eur J Contracept Reprod Health Care 2009;
14: 324–33.
29 Grossman D, Holt K, Pena M, Lara D, Veatch M, Cordova D, et al.
Self-induction of abortion among women in the United States.
Reprod Health Matters 2010;18:136–46.
30 Harvey SM, Beckman LJ, Branch MR. The relationship of contextual
factors to women’s perceptions of medical abortion. Health Care
Women Int 2002;23:654–665.
31 Heller R, Purcell C, Mackay L, Caird L, Cameron ST. Barriers to
accessing termination of pregnancy in a remote and rural setting: a
qualitative study. BJOG 2016;123:1684–91.
2008 ª 2017 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley& Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Purcell et al.
